Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases

scientific article published on February 2002

Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11830548

P50authorAnn F. ChambersQ37828718
P2093author name stringAlan C Groom
Sylvia M Wilson
Ian C MacDonald
Melanie T M Davidson
Hemanth J Varghese
Kishore V Nadkarni
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)887-891
P577publication date2002-02-01
P1433published inCancer ResearchQ326097
P1476titleActivated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases
P478volume62

Reverse relations

cites work (P2860)
Q54989340A New Strategy to Control and Eradicate "Undruggable" Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology
Q27345215A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth
Q37068617Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis.
Q58132083Biomechanics of the Circulating Tumor Cell Microenvironment
Q33264201Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats
Q36071767KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases
Q40653792Novel murine mammary epithelial cell lines that form osteolytic bone metastases: effect of strain background on tumor homing
Q35555401The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status
Q28185519Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter
Q24799059p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways

Search more.